Literature DB >> 1319909

Facilitation of brain stimulation reward by mesencephalic injections of neurotensin-(1-13).

P P Rompré1, P Bauco, A Gratton.   

Abstract

The effects on brain stimulation reward of neurotensin-(1-13) microinjected at different concentrations (2.5, 5, 10 and 20 micrograms/0.5 microliters) into the ventral mesencephalic region containing mesocorticolimbic dopamine neurons were tested in 12 male rats. Neurotensin lowered the stimulation frequency required to sustain threshold levels of responding for brain stimulation reward, suggesting that this neuropeptide is involved in modulating the activity of dopamine neurons that mediate behaviors motivated by positive reinforces. The magnitude of the facilitatory effect of neurotensin on brain stimulation reward was dependent on the concentration injected and to a significant extent also on whether the peptide was administered in an ascending or a descending order of concentration. The different effects of neurotensin depending on the order of administration may suggest long-lasting effects on the responsiveness of neurotensin receptors in this region after injection of high concentrations of the peptide. Subsequent injection of morphine (2.5-5 micrograms/0.5 microliter) into the same site produced a weaker facilitation of brain stimulation reward than expected, suggesting that local damage after multiple central injections or prior injections of neurotensin itself reduced the responsiveness of dopamine neurons to opiates. Taken together, the results are consistent with data indicating that activation of neurotensin receptors in the ventral mesencephalon stimulates dopamine cell firing and axonal dopamine release in limbic terminal fields and suggest that endogenous neurotensin is involved in the control of behavior motivated by positive reinforcement.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319909     DOI: 10.1016/0014-2999(92)90384-g

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

Review 2.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

3.  Neurotensin attenuates the reduction in alcohol drinking produced by angiotensin II.

Authors:  L A Grupp; S Harding
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

4.  Effects of neurotensin gene knockout in mice on the behavioral effects of cocaine.

Authors:  F Scott Hall; Marjorie Centeno; Maria T G Perona; Jordan Adair; Paul R Dobner; George R Uhl
Journal:  Psychopharmacology (Berl)       Date:  2011-07-01       Impact factor: 4.530

5.  Comparison of the locomotor-activating effects of bicuculline infusions into the preoptic area and ventral pallidum.

Authors:  Daniel S Zahm; Zachary M Schwartz; Heather N Lavezzi; Leora Yetnikoff; Kenneth P Parsley
Journal:  Brain Struct Funct       Date:  2013-02-20       Impact factor: 3.270

6.  Role of calcium in neurotensin-evoked enhancement in firing in mesencephalic dopamine neurons.

Authors:  Fannie St-Gelais; Mark Legault; Marie-Josée Bourque; Pierre-Paul Rompré; Louis-Eric Trudeau
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

Review 7.  An update on the connections of the ventral mesencephalic dopaminergic complex.

Authors:  L Yetnikoff; H N Lavezzi; R A Reichard; D S Zahm
Journal:  Neuroscience       Date:  2014-04-13       Impact factor: 3.590

8.  Neurotensin receptor 1 gene (NTSR1) polymorphism is associated with working memory.

Authors:  Jin Li; Chuansheng Chen; Chunhui Chen; Qinghua He; He Li; Jun Li; Robert K Moyzis; Gui Xue; Qi Dong
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

9.  Suppression of Gq Function Using Intra-Pipette Delivery of shRNA during Extracellular Recording in the Ventral Tegmental Area.

Authors:  Sudarat Nimitvilai; Devinder S Arora; Maureen A McElvain; Mark S Brodie
Journal:  Front Cell Neurosci       Date:  2013-02-12       Impact factor: 5.505

10.  Neurotensin receptor 1 deletion decreases methamphetamine self-administration and the associated reduction in dopamine cell firing.

Authors:  Sergio Dominguez-Lopez; Ramaswamy Sharma; Michael J Beckstead
Journal:  Addict Biol       Date:  2019-11-19       Impact factor: 4.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.